Dapagliflozin ((2S)-1,2-propanediol hydrate)

Alias: Dapagliflozin ((2S)-1,2-propanediol, hydrate); BMS-512148 (2S)-1,2-propanediol, hydrate
Cat No.:V28640 Purity: ≥98%
Dapagliflozin ((2S)-1,2-propanediol hydrate) is the S-isomer of Dapagliflozin 1,2-propanediol hydrate, which is an antidiabetic drug used to treat diabetes mellitus (DM).
Dapagliflozin ((2S)-1,2-propanediol hydrate) Chemical Structure CAS No.: 960404-48-2
Product category: SGLT
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
25mg
50mg
100mg
250mg
500mg
1g
5g
Other Sizes

Other Forms of Dapagliflozin ((2S)-1,2-propanediol hydrate):

  • Dapagliflozin (BMS-512148)
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Top Publications Citing lnvivochem Products
Product Description

Dapagliflozin ((2S)-1,2-propanediol hydrate) is the S-isomer of Dapagliflozin 1,2-propanediol hydrate, which is an antidiabetic drug used to treat diabetes mellitus (DM). It functions as a competitive inhibitor of sodium/glucose cotransporter 2 (SGLT2), causing glucose to be excreted into the urine. Dapagliflozin, also known as (2S)-1,2-propanediol, hydrate, attenuates renal IR injury and induces HIF1 expression.

Biological Activity I Assay Protocols (From Reference)
Targets
SGLT2
ln Vitro
Dapagliflozin ((2S)-1,2-propanediol, hydrate) (0-10 μM; 24 hours) greatly improves the cell survival in hypoxic HK2 cells in a dose-dependent manner[2].
Dapagliflozin ((2S)-1,2-propanediol, hydrate) (0–10 μM; 2 hours) elevates HIF1 expression and phosphorylates AMPK and EKR in hypoxic HK2 cells, but has no effect on phosphorylating AMPK and ERK in normoxic HK2 cells[2].
Cell Assay
Cell Line: Hypoxic HK2 cell
Concentration: 0 μM, 1 μM, 2 μM, 5 μM, 10 μM
Incubation Time: 24 hours
Result: Improved the cell viability in a dose-dependent manner compared with control cells.
References

[1]. Dapagliflozin stimulates glucagon secretion at high glucose: experiments and mathematical simulations of human A-cells. Sci Rep. 2016 Aug 18;6:31214.

[2]. Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury. PLoS One. 2016 Jul 8;11(7):e0158810.

[3]. Dapagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor, Acutely Reduces Energy Expenditure in BAT via Neural Signals in Mice. PLoS One. 2016 Mar 10;11(3):e0150756.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C24H35CLO9
Molecular Weight
502.9823
Exact Mass
502.2
CAS #
960404-48-2
Related CAS #
Dapagliflozin; 461432-26-8
Appearance
Powder
SMILES
CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Cl.C[C@@H](CO)O.O
InChi Key
GOADIQFWSVMMRJ-UPGAGZFNSA-N
InChi Code
InChI=1S/C21H25ClO6.C3H8O2.H2O/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21;1-3(5)2-4;/h3-8,10,17-21,23-26H,2,9,11H2,1H3;3-5H,2H2,1H3;1H2/t17-,18-,19+,20-,21+;3-;/m10./s1
Chemical Name
(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol;(2S)-propane-1,2-diol;hydrate
Synonyms
Dapagliflozin ((2S)-1,2-propanediol, hydrate); BMS-512148 (2S)-1,2-propanediol, hydrate
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO: ≥ 100 mg/mL (~198.8 mM)
H2O: ~2.4 mg/mL (~4.7 mM)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 1.9882 mL 9.9408 mL 19.8815 mL
5 mM 0.3976 mL 1.9882 mL 3.9763 mL
10 mM 0.1988 mL 0.9941 mL 1.9882 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Clinical Trial Information
NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT02981966 Active
Recruiting
Drug: Dapagliflozin
Drug: Placebo
Diabetes Mellitus, Type 2 The University of Texas Health Science
Center at San Antonio
May 23, 2019 Phase 4
NCT01714011 Active
Recruiting
Drug: Dapagliflozin 10mg Tab
Drug: Placebo
Chronic Kidney Diseases
Bone Diseases, Metabolic
Mansoura University November 10, 2022 Phase 4
NCT03199053 Active
Recruiting
Drug: Dapagliflozin
Drug: Saxagliptin
Diabetes Mellitus, Type 2 AstraZeneca October 11, 2017 Phase 3
NCT04333823 Active
Recruiting
Drug: Dapagliflozin 5mg
Drug: Placebo
Diabetes Mellitus, Type 1 The Hospital for Sick Children December 11, 2020 Phase 3
NCT03499704 Active
Recruiting
Drug: Dapagliflozin
Drug: Metformin
Diabetes Mellitus, Type 2 Celltrion Pharm, Inc. February 11, 2020 Phase 4
Biological Data
  • Administration of dapagliflozin increased UGE and reduced blood glucose levels. PLoS One . 2016 Mar 10;11(3):e0150756.
  • Dapagliflozin acutely suppressed BAT thermogenesis by reducing sympathetic nerve activity. PLoS One . 2016 Mar 10;11(3):e0150756.
  • Dapagliflozin enhances hepatic gluconeogenesis and glycogenolysis. PLoS One . 2016 Mar 10;11(3):e0150756.
  • Effects of dapagliflozin on renal function (S(n = 5), sham; S + Dapa (n = 5), sham + dapagliflozin; IR(n = 7), vehicle-treated renal IR mice; IR + Dapa (n = 7), dapagliflozin-treated IR mice). PLoS One . 2016 Jul 8;11(7):e0158810.
  • Effects of dapagliflozin on HK2 cell survival and apoptosis. PLoS One . 2016 Jul 8;11(7):e0158810.
  • Ion currents during simulated action potentials during low glucose, high glucose, and high glucose in the presence of dapagliflozin. Sci Rep . 2016 Aug 18:6:31214.
Contact Us Back to top